Article
Tumor suppression. Lessons in p16 from phylum Falconium.
Current biology : CB - 1 Jan 1995
Sheaff R J, Roberts J M
Abstract excerpt
Increasingly, biochemical and genetic evidence indicates that mutations in the gene encoding p16, an inhibitor of cyclin-dependent kinases, may play a role in some forms of hereditary and sporadic tumors.
Topics
- Animals
- Carrier Proteins
- Cell Cycle
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinases
- Genes, Retinoblastoma
- Genes, Tumor Suppressor
- Humans
- Mutation
- Neoplasms
